- Medtech Insight
- >>Business
News We’re Watching: Activist Investor Causes Kerfuffle At Nevro, Lifespin Launches Antibiotic Dx, And More
Medtech Insight's News We're Watching highlights medtech industry news developments that you may have missed over the last few weeks. Last week, EndoQuest closed a $42m round to support its endoluminal surgery system, Intuitive Ventures closed a $150m round, Noah Surgical announced the first biopsy procedures with its Galaxy technology in Asia, the FDA cleared Smileyscope's VR system to reduce needle anxiety, and Guardant will collaborate with Cancer Research UK.
Engaged Capital wants Nevro to focus on achieving profitability instead of acquisitions, according to a report from Bloomberg Law.
In a new 13D filing with the US Securities and Exchange Commission, the Southern California-based activist investor firm disclosed...